NCT05132842
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must have had at least one medical or radiation oncology appointment within the last 3 years at a Sidney Kimmel Cancer Center (SKCC)
Exclusions: Patients not receiving care at a Sidney Kimmel Cancer Center (SKCC)
https://ClinicalTrials.gov/show/NCT05132842